|Bid||1.4400 x 100|
|Ask||1.5300 x 1200|
|Day's Range||0.0385 - 0.0385|
|52 Week Range||0.0385 - 1.8500|
|PE Ratio (TTM)||-0.03|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Shares of Echo Therapeutics Inc. (ECTE) plunged 17.3% to close at $1.48 on Jul 11, after the company announced that it has received a delisting notice from the Nasdaq.
Platinum Partners, the New York-based hedge fund that is in the midst of two investigations, recently informed its investors that it will be liquidating its flagship Platinum Partners Value Arbitrage Fund. In addition, the firm is also considering closing down its Platinum Partners Credit Opportunities Fund. In mid-June, one of the firm’s early backers and […]
Echo Therapeutics, Inc. (Nasdaq: ECTE ) disclosed a fresh patent covering its system, as well as, methods for transdermal monitoring of analytes. This included glucose and other substances. Echo Therapeutics ...